ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2026
Clinical Outcomes After Week-12 Response-Guided Secukinumab Discontinuation in Psoriasis: A Prospective Real-World Cohort Study.
Xin Ma et al.PubMed ↗Publisher ↗
No numbers read from the abstract.